MK2−/− mice are resistant to LPS-induced endotoxic shock [12] and studies using these mice have indicated that MK2 inhibition might be a good treatment option for a variety of chronic inflammatory diseases [13], [26], [27]. The gene discussed is MAPKAPK2; the disease is Shock.